Bruker BRKR Net debt / EBITDA

Net debt / EBITDA at other companies

Thermo Fisher ScientificTMO

3.2×-0.2×

DanaherDHR

3.1×+0.8×

TEC

Bio-TechneTECH

1×0.0×

WAT

Waters CorporationWAT

6.7×+5.6×

Agilent TechnologiesA

0.9×-0.3×

RevvityRVTY

4×+1.2×

FAQ

What is Bruker's net debt / EBITDA?

Bruker (BRKR) reported net debt / EBITDA of 8.2× in Q2 2026.

How has Bruker's net debt / EBITDA changed year-over-year?

Bruker's net debt / EBITDA increased by 38.2% year-over-year, from 5.9× to 8.2×.

What is the long-term trend for Bruker's net debt / EBITDA?

Over 5 years (2020 to 2025), Bruker's net debt / EBITDA has grown at a 54.1% compound annual growth rate (CAGR), from 0.7× to 6.1×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.